Two-Drug combo tested to control untreated lymphoma
NCT ID NCT01316523
Summary
This study tested whether combining two existing drugs, lenalidomide and rituximab, could effectively treat adults with a slow-growing type of non-Hodgkin's lymphoma who had not received any prior treatment. The goal was to see if this drug combination could shrink tumors and control the disease. The trial enrolled 30 patients to measure how well they responded and how long the treatment worked.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN'S LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Sutter Pacific Medical Foundation
Santa Rosa, California, 95403, United States
-
University of California Davis Cancer Center
Sacramento, California, 95817, United States
Conditions
Explore the condition pages connected to this study.